BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas will be speaking on two panels, Starting Up Biotechs in the New Normal World and Success in the States: A Guide for Foreign Companies to the Largest Venture Capital Pool in the World, at the Bio 2011 conference in Washington, D.C.
News | 06. 29. 2011
